Cargando…

Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder

Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberman, Joshua, Pesa, Jacqueline, Rui, Pinyao, Joshi, Kruti, Harding, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935983/
https://www.ncbi.nlm.nih.gov/pubmed/36800597
http://dx.doi.org/10.1097/MD.0000000000032895
_version_ 1784890135610916864
author Liberman, Joshua
Pesa, Jacqueline
Rui, Pinyao
Joshi, Kruti
Harding, Lisa
author_facet Liberman, Joshua
Pesa, Jacqueline
Rui, Pinyao
Joshi, Kruti
Harding, Lisa
author_sort Liberman, Joshua
collection PubMed
description Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted a retrospective cohort study among 308 US adults initiating ESK between October 11, 2019 and December 31, 2020 and 1540 propensity-score matched controls with treatment-resistant depression or major depression with suicidal ideation. Adjusting for demographics, prior health care utilization and comorbidities, social determinant variables and distance were regressed separately on each outcome: ESK initiation, failure to complete induction (8 treatments in 45 days), and discontinuation within 6 months. ESK initiation was associated with higher population density (odds ratio [OR]: 2.12), American Indian, Alaska Native, Native Hawaiian, Other Pacific Islander (OR: 3.19), and mental health (OR: 1.55) and primary care providers (OR: 1.55) per capita. Lower likelihood of ESK initiation was associated with living > 7.2 miles from a treatment center (OR: 0.75), living in rural areas (OR: 0.64), and percent non-Hispanic African American (OR: 0.58) and Hispanic (OR: 0.40). Health care providers should tailor patient engagement strategies to mitigate potential barriers to initiating and continuing appropriate treatment. Failing to complete induction was associated with substance use disorder and longer distance to treatment center was associated with discontinuation (hazard ratio: 1.48), as was percent Asian population (hazard ratio: 1.37). Prior psychiatric care and residence in counties with high rates of primary care providers per capita, unemployment, and high school graduation were associated with both higher likelihood of completing induction and lower likelihood of discontinuation.
format Online
Article
Text
id pubmed-9935983
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99359832023-02-18 Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder Liberman, Joshua Pesa, Jacqueline Rui, Pinyao Joshi, Kruti Harding, Lisa Medicine (Baltimore) 5000 Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted a retrospective cohort study among 308 US adults initiating ESK between October 11, 2019 and December 31, 2020 and 1540 propensity-score matched controls with treatment-resistant depression or major depression with suicidal ideation. Adjusting for demographics, prior health care utilization and comorbidities, social determinant variables and distance were regressed separately on each outcome: ESK initiation, failure to complete induction (8 treatments in 45 days), and discontinuation within 6 months. ESK initiation was associated with higher population density (odds ratio [OR]: 2.12), American Indian, Alaska Native, Native Hawaiian, Other Pacific Islander (OR: 3.19), and mental health (OR: 1.55) and primary care providers (OR: 1.55) per capita. Lower likelihood of ESK initiation was associated with living > 7.2 miles from a treatment center (OR: 0.75), living in rural areas (OR: 0.64), and percent non-Hispanic African American (OR: 0.58) and Hispanic (OR: 0.40). Health care providers should tailor patient engagement strategies to mitigate potential barriers to initiating and continuing appropriate treatment. Failing to complete induction was associated with substance use disorder and longer distance to treatment center was associated with discontinuation (hazard ratio: 1.48), as was percent Asian population (hazard ratio: 1.37). Prior psychiatric care and residence in counties with high rates of primary care providers per capita, unemployment, and high school graduation were associated with both higher likelihood of completing induction and lower likelihood of discontinuation. Lippincott Williams & Wilkins 2023-02-17 /pmc/articles/PMC9935983/ /pubmed/36800597 http://dx.doi.org/10.1097/MD.0000000000032895 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5000
Liberman, Joshua
Pesa, Jacqueline
Rui, Pinyao
Joshi, Kruti
Harding, Lisa
Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title_full Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title_fullStr Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title_full_unstemmed Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title_short Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
title_sort social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
topic 5000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935983/
https://www.ncbi.nlm.nih.gov/pubmed/36800597
http://dx.doi.org/10.1097/MD.0000000000032895
work_keys_str_mv AT libermanjoshua socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder
AT pesajacqueline socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder
AT ruipinyao socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder
AT joshikruti socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder
AT hardinglisa socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder